Jim Corbett

The unpublished Henry Ford study is explosive in its implications. At its core, the data reveal a stark divide between children who received vaccines and those who did not. When measured in incidence rates per one million patient-years, the differences are not subtle. They are dramatic, and they cut across a wide spectrum of chronic conditions. The most basic finding is that vaccinated children experienced nearly two and a half times the overall rate of chronic health conditions compared to their unvaccinated peers. The number sits at 277.3 cases per million patient-years among vaccinated children against 111.7 for the unvaccinated, producing an incidence rate ratio of 2.48 with tight confidence intervals. That is not a minor signal, it is a flashing red light. Asthma stands out as one of the most glaring disparities. The rate was over four times higher in vaccinated children, 145.6 cases compared to only 35.6 among the unvaccinated. Atopic diseases such as eczema and allergies were also elevated, with vaccinated children facing a 2.64-fold higher risk. Autoimmune conditions were even more striking, with vaccinated children showing an incidence more than six times greater than their unvaccinated counterparts. Neurodevelopmental outcomes were perhaps the most disturbing category. Disorders in this group were more than six times higher in vaccinated children. ADHD was present in 262 cases among the vaccinated group, yet zero among the unvaccinated. Learning disabilities, intellectual disabilities, tics, and other developmental impairments all followed a similar pattern. Speech disorders were four times higher among the vaccinated group, and developmental delays nearly four times higher as well. Mental health disorders overall were 3.5 times higher. Even seizure disorders, while less dramatic, still trended upwards with a relative risk of 1.63. One of the most telling features of the data is how often the unvaccinated column registers as zero or near zero. ADHD, learning disabilities, intellectual disabilities, and tics had no cases recorded in the unvaccinated population. Critics will argue this reflects underdiagnosis, since unvaccinated children typically see doctors less often. But the sheer size of the disparity suggests something more. A minor diagnostic gap might be plausible, but the gulf revealed in these numbers is difficult to dismiss as mere chance or office visit frequency. Taken together, the Henry Ford analysis suggests vaccinated children are not only more likely to be seen by physicians but also genuinely more likely to be diagnosed with an array of chronic and developmental problems. Even if one accepts the possibility of detection bias, the magnitude of the differences requires serious investigation rather than casual dismissal. If the signal were a modest ten or twenty percent increase, one could argue it away. When the risks climb to four, five, or even six times higher, the argument of bias alone becomes increasingly fragile. The larger point is this. Whether or not one accepts every conclusion of the Henry Ford team, this study provides a powerful signal that chronic conditions deserve a deeper look in relation to vaccination. Current post-marketing surveillance systems are primarily designed to catch rare acute events such as anaphylaxis or febrile seizures. They are not equipped to track long-term patterns in asthma, autoimmune disease, or developmental disorders. By design, they will not see what this study has begun to uncover. To dismiss this analysis outright because it has not yet passed through peer review is an act of intellectual laziness. Publication is not the only measure of value, and in today’s climate researchers face professional punishment for producing findings that challenge the dominant narrative.